C. Lumley – författare
Visar alla böcker från författaren C. Lumley. Handla med fri frakt och snabb leverans.
11 produkter
Improving the Regulatory Review Process
Industry and Regulatory Initiatives
Av C. Lumley, S.R. Walker
Inbunden, 1996
1692 kr
Lägg i varukorg
Regulatory review is the last major development hurdle that must be passed by a new medicine before it reaches the market. At a time when pharmaceutical companies are reviewing their R&D strategies, and attempting to reduce drug development times, it is extremely important that the review process …
Safety Evaluation of Biotechnologically-derived Pharmaceuticals
Facilitating a Scientific Approach
Av Susan A. Griffiths, C. Lumley
Inbunden, 1998
1130 kr
Lägg i varukorg
Considerable investment has been made by both pharmaceutical and biotechnology companies in pharmaceutical products of biotechnology. However, because relatively few of these products have been marketed, lack of relevant experience means that uncertainty still surrounds the most appropriate …
Timing of Toxicological Studies to Support Clinical Trials
Av C. Parkinson, N. McAuslane m. fl.
Inbunden, 1995
1130 kr
Lägg i varukorg
The timing of toxicological studies in relation to the clinical evaluation of new medicines is a key topic for strategic planners in the industry and those involved with harmonization. Resolving the anomalies between different regulatory authorities should eliminate redundant testing on animals and …
Improving the Regulatory Review Process
Industry and Regulatory Initiatives
Av S.R. Walker, C. Lumley
E-bok, 2012
1942 kr
Lägg i varukorg
Regulatory review is the last major development hurdle that must be passed by a new medicine before it reaches the market. At a time when pharmaceutical companies are reviewing their R&D strategies, and attempting to reduce drug development times, it is extremely important that the review process …
Relevance of Ethnic Factors in the Clinical Evaluation of Medicines
Proceedings of a Workshop held at The Medical Society of London, UK, 7th and 8th July, 1993
Av S.R. Walker, C. Lumley m. fl.
Häftad, 2012
569 kr
Lägg i varukorg
For a research-based pharmaceutical company to be successful in the 1990s. it must have a strategic plan for the global development of new chemical entities. Global development can be defined as an attempt to reach all major markets as rapidly as possible and for many companies these will include …
Timing of Toxicological Studies to Support Clinical Trials
Av C. Parkinson, N. McAuslane m. fl.
Häftad, 2012
1128 kr
Lägg i varukorg
Over the past twelve years, the Centre for Medicines Research has held a series of Workshops on a number of topics related to the drug discovery and development process. The major objective of these Workshops has been to provide an international forum for regula tory, academic and industry …
Safety Evaluation of Biotechnologically-derived Pharmaceuticals
Facilitating a Scientific Approach
Av Susan A. Griffiths, C. Lumley
Häftad, 2012
1010 kr
Lägg i varukorg
Considerable investment has been made by both pharmaceutical and biotechnology companies in pharmaceutical products of biotechnology. However, because relatively few of these products have been marketed, lack of relevant experience means that uncertainty still surrounds the most appropriate …
Improving the Regulatory Review Process
Industry and Regulatory Initiatives
Av C. Lumley, S.R. Walker
Häftad, 2011
1511 kr
Lägg i varukorg
Regulatory review is the last major development hurdle that must be passed by a new medicine before it reaches the market. At a time when pharmaceutical companies are reviewing their R&D strategies, and attempting to reduce drug development times, it is extremely important that the review process …
Relevance of Ethnic Factors in the Clinical Evaluation of Medicines
Proceedings of a Workshop held at The Medical Society of London, UK, 7th and 8th July, 1993
Av N. McAuslane, C. Lumley m. fl.
E-bok, 2012
755 kr
Lägg i varukorg
For a research-based pharmaceutical company to be successful in the 1990s. it must have a strategic plan for the global development of new chemical entities. Global development can be defined as an attempt to reach all major markets as rapidly as possible and for many companies these will include …
Timing of Toxicological Studies to Support Clinical Trials
Av S.R. Walker, C. Lumley m. fl.
E-bok, 2012
1502 kr
Lägg i varukorg
Over the past twelve years, the Centre for Medicines Research has held a series of Workshops on a number of topics related to the drug discovery and development process. The major objective of these Workshops has been to provide an international forum for regula tory, academic and industry …
Safety Evaluation of Biotechnologically-derived Pharmaceuticals
Facilitating a Scientific Approach
Av C. Lumley, Susan A. Griffiths
E-bok, 2012
1342 kr
Lägg i varukorg
Considerable investment has been made by both pharmaceutical and biotechnology companies in pharmaceutical products of biotechnology. However, because relatively few of these products have been marketed, lack of relevant experience means that uncertainty still surrounds the most appropriate …
